遗传性血色病基因变异与常见疾病关联:英国生物银行队列研究
该研究基于英国生物银行451 243名欧洲裔志愿者,比较HFE p.C282Y变异携带者与无变异者的疾病患病率和发病率。随访7年发现,p.C282Y纯合子男性血色病诊断率21.7%,女性9.8%,且与肝病、类风湿关节炎、骨关节炎和糖尿病风险升高相关。研究提示应重新评估早期病例发现和筛查策略。
要点
- p.C282Y纯合子男性血色病诊断率21.7%,女性9.8%。
- 纯合子男性肝病、类风湿关节炎、骨关节炎和糖尿病风险显著升高。
- 7年随访中15.7%纯合子男性发生至少一种关联疾病,显著高于无变异者的5.0%。
核心结论
- HFE p.C282Y纯合子与男性和女性中显著较高的现患和 incident 临床诊断疾病负担相关。
- 鉴于p.C282Y相关铁过载早期干预可预防和治疗,研究结果支持重新审视扩大早期病例发现和筛查的选择。
研究设计与样本
- 平均随访7年(最长9.4年),通过医院住院诊断和死亡证明获取结局。
- 采用比值比和Cox风险比比较有无血色病突变者疾病率,校正年龄、基因分型阵列类型和遗传主成分,男女分开分析。
主要发现
- 2890名p.C282Y纯合子(0.6%,即1/156)中,随访结束时男性血色病诊断率21.7%(95%CI 19.5%至24.1%,281/1294),女性9.8%(8.4%至11.2%,156/1596)。
- 40至70岁p.C282Y纯合子男性相比无p.C282Y突变者(n=175 539),诊断血色病OR 411.1(95%CI 299.0至565.3,P<0.001),肝病OR 4.30(2.97至6.18,P<0.001),类风湿关节炎OR 2.23(1.51至3.31,P<0.001),骨关节炎OR 2.01(1.71至2.36,P<0.001),糖尿病OR 1.53(1.16至1.98,P=0.002)。
- 7年随访期间,15.7%纯合子男性发生至少一种关联疾病,无p.C282Y突变者为5.0%(P<0.001);女性分别为10.1%和3.4%(P<0.001)。
- p.C282Y/p.H63D杂合子中血色病诊断更常见,但超额疾病负担较小。
临床怎么用
- 对p.C282Y纯合子个体,尤其男性,应关注血色病及肝病、关节炎、糖尿病等关联疾病的早期识别。
- 研究结果提示可考虑扩大早期病例发现和筛查策略,但需结合进一步评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare prevalent and incident morbidity and mortality between those with the HFE p.C282Y genetic variant (responsible for most hereditary haemochromatosis type 1) and those with no p.C282Y mutations, in a large UK community sample of European descent. DESIGN: Cohort study. SETTING: 22 centres across England, Scotland, and Wales in UK Biobank (2006-10). PARTICIPANTS: 451 243 volunteers of European descent aged 40 to 70 years, with a mean follow-up of seven years (maximum 9.4 years) through hospital inpatient diagnoses and death certification. MAIN OUTCOME MEASURE: Odds ratios and Cox hazard ratios of disease rates between participants with and without the haemochromatosis mutations, adjusted for age, genotyping array type, and genetic principal components. The sexes were analysed separately as morbidity due to iron excess occurs later in women. RESULTS: Of 2890 participants homozygous for p.C282Y (0.6%, or 1 in 156), haemochromatosis was diagnosed in 21.7% (95% confidence interval 19.5% to 24.1%, 281/1294) of men and 9.8% (8.4% to 11.2%, 156/1596) of women by end of follow-up. p.C282Y homozygous men aged 40 to 70 had a higher prevalence of diagnosed haemochromatosis (odds ratio 411.1, 95% confidence interval 299.0 to 565.3, P<0.001), liver disease (4.30, 2.97 to 6.18, P<0.001), rheumatoid arthritis (2.23, 1.51 to 3.31, P<0.001), osteoarthritis (2.01, 1.71 to 2.36, P<0.001), and diabetes mellitus (1.53, 1.16 to 1.98, P=0.002), versus no p.C282Y mutations (n=175 539). During the seven year follow-up, 15.7% of homozygous men developed at least one incident associated condition versus 5.0% (P<0.001) with no p.C282Y mutations (women 10.1% v 3.4%, P<0.001). Haemochromatosis diagnoses were more common in p.C282Y/p.H63D heterozygotes, but excess morbidity was modest. CONCLUSIONS: In a large community sample, HFE p.C282Y homozygosity was associated with substantial prevalent and incident clinically diagnosed morbidity in both men and women. As p.C282Y associated iron overload is preventable and treatable if intervention starts early, these findings justify re-examination of options for expanded early case ascertainment and screening.
引用
- Pilling LC, Tamosauskaite J, Jones G, et al. Common conditions associated with hereditary haemochromatosis genetic variants: cohort study in UK Biobank. BMJ. 2019. PMID: 30651232. doi:10.1136/bmj.k5222
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。